Oligomerix

About:

Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.

Website: http://www.oligomerix.com

Twitter/X: oligomerix

Top Investors: National Institutes of Health, National Institute on Aging, Small Business Innovation Research, Wheatley Partners, Durand Venture Associates

Description:

Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.